Poultry Vaccine Market, By Disease (Bronchitis, Avian Influenza, Newcastle disease, Marek\'s Disease, and Other Diseases), By Technology (Live Attenuated Vaccines (LAV), Recombinant Vaccines, Inactivated Vaccines, and Other Technologies), and By Geography (North America, Europe, Asia Pacific, Middle East and Africa, and Latin America)-

Published In : Feb 2023

Code : CMI5527

Pages :170

Formats :

Excel and PDF

Industry : Pharmaceutical

Market News

Global Poultry Vaccine Market: Key Developments

In October 2022, Zoetis expanded its poultry vaccine portfolio with the introduction of Poulvac Procerta HVT-IBD-ND, a recombinant vector vaccine that provides early/robust protection against Marek’s, infectious bursal and Newcastle disease viruses with one dose.

In April 2022, Elanco, in collaboration with Ginkgo Bioworks, launched a new animal healthcare company called BiomEdit to develop drugs, nutritional products, and disease-monitoring methods for livestock. The new firm hopes to address antibiotic resistance and improve sustainability.

In January 2020, Boehringer Ingelheim announced the launch of the VAXXITEK HVT+IBD+ND vaccine to protect poultry against various diseases, such as Newcastle Disease, Marek’s Disease, and Infectious Bursal Disease (classic and variant types).

In September 2019, Boehringer Ingelheim started developing the largest biotechnology production sites for veterinary vaccines in Europe, building on France’s pioneering expertise in the veterinary public health (VPH). The company will invest 200 million euro into this high-tech complex.